Matt Abernethy

Insider Reports History

Location: C/O Neurocrine Biosciences, Inc., 12780 El Camino Real, San Diego, CA
Signature: /s/ Cindy R. Tahl, as Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matt Abernethy:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
NEUROCRINE BIOSCIENCES INC	Chief Financial Officer	Common Stock	35.8K	$4.19M	$116.87	Feb 13, 2025	Direct
NEUROCRINE BIOSCIENCES INC	Chief Financial Officer	Restricted Stock Unit	6.73K	$795K	$118.28	Feb 13, 2025	Direct
NEUROCRINE BIOSCIENCES INC	Chief Financial Officer	Restricted Stock Unit	8.97K	$388K	$43.24	Feb 13, 2024	Direct
NEUROCRINE BIOSCIENCES INC	Chief Financial Officer	Non-Qualified Stock Option	0	$0	$73.60	Aug 13, 2024	Direct
FATE THERAPEUTICS INC	Director	Stock Option (Right to Buy)	110K			May 29, 2025	Direct
NEUROCRINE BIOSCIENCES INC	Chief Financial Officer	Stock Option	45.5K			Feb 12, 2025	Direct
NEUROCRINE BIOSCIENCES INC	Chief Financial Officer	Stock Option	45.1K			Feb 13, 2024	Direct

Showing 1 to 7 of 7 entries

Insider Reports Filed by Matt Abernethy

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
FATE	FATE THERAPEUTICS INC	May 29, 2025	1	$0	4	May 30, 2025	Director
FATE	FATE THERAPEUTICS INC	May 29, 2025	0	$0	3	May 30, 2025	Director
NBIX	NEUROCRINE BIOSCIENCES INC	Feb 12, 2025	8	-$299K	4	Feb 14, 2025	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Feb 8, 2025	3	-$116K	4	Feb 12, 2025	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Jan 31, 2025	3	-$196K	4	Feb 4, 2025	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Aug 13, 2024	3	-$1.08M	4	Aug 15, 2024	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Jul 16, 2024	3	-$68.8K	4	Jul 18, 2024	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	May 14, 2024	6	-$4.14M	4	May 16, 2024	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Feb 13, 2024	3	-$180K	4	Feb 15, 2024	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Feb 6, 2024	2	-$314K	4	Feb 8, 2024	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Jan 31, 2024	1	-$181K	4	Feb 2, 2024	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Aug 21, 2023	1	-$229K	4	Aug 23, 2023	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Feb 13, 2023	2	$0	4	Feb 15, 2023	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Feb 6, 2023	5	-$2.93M	4	Feb 8, 2023	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Jan 31, 2023	1	-$141K	4	Feb 2, 2023	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Feb 7, 2022	3	-$345K	4	Feb 9, 2022	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Jan 31, 2022	2	$0	4	Feb 2, 2022	Chief Financial Officer
NBIX	NEUROCRINE BIOSCIENCES INC	Dec 1, 2021	1	-$136K	4	Dec 3, 2021	Chief Financial Officer